Bora CDMO Bora CDMO

X

Digital content for OWP Pharmaceuticals

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
OWP Pharmaceuticals
United_States_of_America Flag

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

http://www.pharmabiz.com/NewsDetails.aspx?aid=145069&sid=2

PHARMABIZ
06 Jan 2022

https://www.globenewswire.com/news-release/2021/11/17/2336301/0/en/OWP-Pharmaceuticals-Announces-IND-Authorization-for-the-First-Ever-Oral-Liquid-Formulation-of-Atomoxetine-Hydrochloride-for-the-Treatment-of-Attention-Deficit-Hyperactivity-Disorde.html

GLOBENEWSWIRE
17 Nov 2021

https://www.globenewswire.com/news-release/2021/07/01/2256446/0/en/OWP-Pharmaceuticals-Announces-Patent-Issuance-for-the-First-Ever-Oral-Liquid-Suspension-of-Quetiapine-for-the-Treatment-of-Schizophrenia-and-Bipolar-Disorder.html

GLOBENEWSWIRE
01 Jul 2021

https://www.globenewswire.com/news-release/2021/04/22/2215011/0/en/OWP-Pharmaceuticals-Announces-Patent-Application-for-the-First-Ever-Oral-Liquid-Formulation-of-Atomoxetine-Hydrochloride-for-the-Treatment-of-Attention-Deficit-Hyperactivity-Disord.html

GLOBENEWSWIRE
22 Apr 2021

https://www.biospace.com/article/releases/owp-pharmaceuticals-announces-ind-approval-for-the-first-ever-liquid-oral-suspension-formulation-of-quetiapine-fumarate-for-the-treatment-of-schizophrenia-and-bipolar-disorder/

BIOSPACE
07 Oct 2020

https://www.globenewswire.com/news-release/2020/07/08/2059215/0/en/OWP-Pharmaceuticals-Announces-Patent-Application-for-the-First-Ever-Powder-for-Oral-Liquid-Formulation-of-Duloxetine-Hydrochloride-for-the-Treatment-of-Major-Depressive-and-General.html

GLOBENEWSWIRE
08 Jul 2020

https://www.globenewswire.com/news-release/2020/01/08/1967787/0/en/OWP-Pharmaceuticals-Announces-Pre-IND-Acknowledgement-and-Patent-Application-for-the-First-Ever-Liquid-Oral-Suspension-Formulation-of-Quetiapine-Fumarate-for-the-Treatment-of-Schiz.html

GLOBE NEWSWIRE
08 Jan 2020

https://www.globenewswire.com/news-release/2020/01/08/1967787/0/en/OWP-Pharmaceuticals-Announces-Pre-IND-Acknowledgement-and-Patent-Application-for-the-First-Ever-Liquid-Oral-Suspension-Formulation-of-Quetiapine-Fumarate-for-the-Treatment-of-Schiz.html

GLOBE NEWSWIRE
07 Jan 2020

https://www.globenewswire.com/news-release/2020/01/08/1967787/0/en/OWP-Pharmaceuticals-Announces-Pre-IND-Acknowledgement-and-Patent-Application-for-the-First-Ever-Liquid-Oral-Suspension-Formulation-of-Quetiapine-Fumarate-for-the-Treatment-of-Schiz.html

GLOBE NEWSWIRE
07 Jan 2020
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY